Further immunohistochemical staining (Fig. 8J) confirmed the inhibition of LCN2 expression in the NPs-siLCN2 group, and the levels of p-EGFR and the tumor proliferation index Ki67 were also decreased. The gene discussed is EGFR; the disease is neoplasm.